Synopsis
0
USDMF
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
Severity: Warning
Message: include(../assets/text/seoInfo/46783759.txt): Failed to open stream: No such file or directory
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
Severity: Warning
Message: include(): Failed opening '../assets/text/seoInfo/46783759.txt' for inclusion (include_path='.:/usr/share/pear:/usr/share/php')
Filename: include/seoInfo.php
Line Number: 77
Backtrace:
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: _error_handler
File: /var/www/html/application/views/include/seoInfo.php
Line: 77
Function: include
File: /var/www/html/application/views/include/product/indexNew.php
Line: 1266
Function: include
File: /var/www/html/application/views/commonNew.php
Line: 442
Function: include
File: /var/www/html/application/controllers/Search.php
Line: 1720
Function: view
File: /var/www/html/index.php
Line: 224
Function: require_once
A Hydroxocobalamin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxocobalamin Hydrochloride, including repackagers and relabelers. The FDA regulates Hydroxocobalamin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxocobalamin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hydroxocobalamin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hydroxocobalamin Hydrochloride supplier is an individual or a company that provides Hydroxocobalamin Hydrochloride active pharmaceutical ingredient (API) or Hydroxocobalamin Hydrochloride finished formulations upon request. The Hydroxocobalamin Hydrochloride suppliers may include Hydroxocobalamin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Hydroxocobalamin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hydroxocobalamin Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Hydroxocobalamin Hydrochloride Certificate of Suitability (COS). The purpose of a Hydroxocobalamin Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Hydroxocobalamin Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Hydroxocobalamin Hydrochloride to their clients by showing that a Hydroxocobalamin Hydrochloride CEP has been issued for it. The manufacturer submits a Hydroxocobalamin Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Hydroxocobalamin Hydrochloride CEP holder for the record. Additionally, the data presented in the Hydroxocobalamin Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Hydroxocobalamin Hydrochloride DMF.
A Hydroxocobalamin Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Hydroxocobalamin Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Hydroxocobalamin Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Hydroxocobalamin Hydrochloride written confirmation (Hydroxocobalamin Hydrochloride WC) is an official document issued by a regulatory agency to a Hydroxocobalamin Hydrochloride manufacturer, verifying that the manufacturing facility of a Hydroxocobalamin Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Hydroxocobalamin Hydrochloride APIs or Hydroxocobalamin Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Hydroxocobalamin Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Hydroxocobalamin Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Hydroxocobalamin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Hydroxocobalamin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Hydroxocobalamin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Hydroxocobalamin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Hydroxocobalamin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Hydroxocobalamin Hydrochloride suppliers with NDC on PharmaCompass.
Hydroxocobalamin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxocobalamin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxocobalamin Hydrochloride GMP manufacturer or Hydroxocobalamin Hydrochloride GMP API supplier for your needs.
A Hydroxocobalamin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Hydroxocobalamin Hydrochloride's compliance with Hydroxocobalamin Hydrochloride specifications and serves as a tool for batch-level quality control.
Hydroxocobalamin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxocobalamin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxocobalamin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxocobalamin Hydrochloride EP), Hydroxocobalamin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxocobalamin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
